Smoking Linked to Skin Cancer in Women (HealthDay)

Dec 15, 2011 Posted Under: Health Quotes  

THURSDAY, Dec 15 HealthDay News — If youre a woman who smokes and you are looking for another reason to quit, consider this: A new study has found a link between tobacco use and skin cancer

The study found that women who had squamous cell skin cancer were more likely to have smoked than those who were free from the disease And those who smoked at least 20 years were twice as likely to develop squamous cell skin cancer, a less aggressive form of skin cancer than melanoma

Men who smoked had a modest risk for the two types of non-melanoma skin cancer — basal cell and squamous cell cancer — but the results werent statistically significant, the study authors noted

“We dont know why,” said study lead author Dana Rollison, referring to the difference between womens and mens risk Both men and women get a lot of exposure to the sun, the main risk factor for skin cancer, she noted

But lung cancer research may offer a clue, said Rollison, an associate member in the Moffitt Cancer Center department of cancer epidemiology, in Tampa, Fla Hormonal differences affecting the metabolization of nicotine and the bodys ability to repair damage to lung DNA caused by smoking have been noted before, suggesting that the female hormone estrogen may play a role, she said

The study, published online in the journal Cancer Causes Control, was done at the Moffitt Cancer Center and the University of South Florida, also in Tampa

For the study, 383 patients with skin cancer were compared to 315 people without the disease The participants were asked how much they smoked, when they picked up the habit and the total number of years theyd smoked A total of 355 men and 343 women were included in the study All were white, the group most at risk for skin cancer Risks for both types of non-melanoma skin cancer were analyzed separately, compensating for the presence of other risk factors

The researchers found that the more people smoked, the more likely they were to have skin cancer, Rollison said Men who had basal cell skin cancer were significantly more likely to have smoked for at least 20 years than men with no cancer, the study authors noted

While the study found an association between smoking and skin cancer risk, it did not prove a cause and effect

Despite the elevated smoking-related risk among women, men overall are more likely to get skin cancer, Rollison noted She said that “it is possible mens skin is more sensitive to sun exposure than womens”

But another skin cancer expert suggested that men may be less inclined to use sunscreen or other protection when outdoors

“Although it could just be a genetic difference between men and women, men tend to have more unprotected sun exposure in their lives,” said Dr Jeffrey Dover, associate clinical professor of dermatology at Yale University Medical School

Dover said the study findings werent surprising because “we know cigarette smoke contains carcinogens” and smokers are “blowing the smoke and ash around their faces all day”

The study is important, he added, because “although we have done well, we can do even better” at eliminating smoking as a cause of disease “This adds more fuel to the idea that smoking has no place in our society”

Non-melanoma skin cancer is the most common form of cancer in the United States, where about 2 million cases are treated annually, according to the US National Institutes of Health Squamous cell cancer occurs in the epidermis, the top layer of skin, and can spread to other organs Basal cell skin cancer occurs in the dermis, the skin layer beneath the epidermis While it does not spread to other organs, it is far more common than squamous cell cancer, according to the government agency

More information

To learn more about skin cancer, visit the US National Cancer Institute

Life Sciences Startup PhotOral Licenses Patented Oral Blue-Light Technology From Forsyth Institute

Dec 14, 2011 Posted Under: Health Words  

   

PhotOral will create first intraoral device using blue light as non-invasive weapon against pathogenic bacteria

BOSTON, /PRNewswire/ — Life sciences startupPhotOralannounced today it has licensed a patented technology from Harvard-affiliated Forsyth Institute to develop a novel intraoral device that uses blue light for targeting and obliterating potentially harmful dental plaque microorganisms.

The agreement empowers newly-launched PhotOral to commercialize Forsyth’s photomedicine portfolio, addressing the $7 billion oral care market.PhotOral Founder and CEO, Stamatis Astra says he’s in the midst of fundraising an initial round to support prototype production, clinical trials, and marketing operations.”Our goal is to have the first intraoral light cleaning device available by late 2012,” explains Astra.”We are honored to be working closely with Forsyth experts to create a portfolio of blue light therapy products, ultimately creating an evolutionary move in the oral care experience.”

Forsyth Institute, the leader in oral and craniofacial research, will conduct PhotOral’s clinical trials. I

Find more info…

First lady Michelle Obama helps to break world jumping jacks record

Dec 13, 2011 Posted Under: Health Guide  

WASHINGTON Michelle Obama now holds part of a world record.

The first lady announced in an email Monday that her October bid to break the record for the most people doing jumping jacks in a 24-hour period succeeded. Mrs. Obama says 300,265 people participated, shattering the old record.

In order to achieve her goal, Mrs. Obama led about 400 elementary and middle-school students from Washington in jumping jacks on the South Lawn of the White House. Other jumping jacks events were held around the world on Oct. 11.

The effort was organized by National Geographic Kids magazine in support of the first ladys Lets Move!

Find more info…

Two New Drug Combos May Fight Advanced Breast Cancers

Dec 11, 2011 Posted Under: Health Quotes  

Breast cancer researchers report they are heartened by the results of two new studies that show combination therapies might improve survival for women with two different types of advanced tumors.

One of the drugs, everolimus (Afinitor), boosted progression-free survival in women with hormone receptor-positive breast cancer but is not yet approved by the U.S. Food and Drug Administration for this indication. The other drug, pertuzumab, improved survival with HER-2 positive tumors, but has not received any FDA approval.

So, the immediate clinical implications are probably “none,” said Dr.

Find more info…

People with DFNA2 hearing loss show increased touch sensitivity

Dec 7, 2011 Posted Under: Health Words  

People with a certain form of inherited hearing loss have increased sensitivity to low frequency vibration, according to a study by Professor Thomas Jentsch of the Leibniz-Institut fr Molekulare Pharmakologie (FMP)/Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), conducted in cooperation with clinicians from Madrid, Spain and Nijmegen, the Netherlands. The research findings, which were published in , reveal previously unknown relationships between hearing loss and touch sensitivity: In order to be able to ‘feel’, specialized cells in the skin must be tuned like instruments in an orchestra.

Find more info…

Difficult to diagnose lazy eye in young children

Dec 2, 2011 Posted Under: Health Guide  

Amblyopia, or lazy eye, is the most common cause of vision problems in children. Only about one in three kids show physical symptoms. Now, as KING 5′s Jean Enersen shows us, a doctor’s invention is helping catch it much earlier.

Page 4 of 44« First...23456...102030...Last »